耳鼻咽喉科

订阅

MedSci主页 / 所有栏目 / 耳鼻咽喉科

长时间使用止痛剂可增加听力损失的风险

2016-12-16 sunshien MedSci原创

听力损失阿司匹林乙酰氨基酚非甾体类抗炎药
关注

近日，来自哈佛医学院和波士顿妇女医院的研究人员发现，使用对乙酰氨基酚或非甾体类抗炎药如布洛芬6年及以上的女性来说，其听力丧失的风险较未使用如此长时间的女性高，其研究成果已发表于American Journal of Epidemiology。研究人员使用了55850名参加护士健康研究的女性的数据，分析这些女性自述的听力损失与其使用布洛芬、对乙酰氨基酚和阿司匹林之间的联系。结果表明，长期使用（持续6

近日，来自哈佛医学院和波士顿妇女医院的研究人员发现，使用对乙酰氨基酚或非甾体类抗炎药如布洛芬6年及以上的女性来说，其听力丧失的风险较未使用如此长时间的女性高，其研究成果已发表于American Journal of Epidemiology。

研究人员使用了55850名参加护士健康研究的女性的数据，分析这些女性自述的听力损失与其使用布洛芬、对乙酰氨基酚和阿司匹林之间的联系。

结果表明，长期使用（持续6年以上）布洛芬和对乙酰氨基酚可增加女性听力损失的风险，分别增加10%和9%（对照者为使用这些药物不足1年的女性）。

但是研究人员并为发现常用剂量阿司匹林的使用与听力损失之间的关联。已知高剂量阿司匹林的使用可导致听力损失，但是在过去的2年里已很少使用如此高剂量的阿司匹林。

越来越多的研究表明NSAIDs或对乙酰氨基酚与听力损失之间存在关联，尽管其潜在的生物学机制目前尚未清楚。

研究人员表示，应该二者为因果联系，那么该研究中约16.2%的听力损失女性或是由于布洛芬或对乙酰氨基酚是的使用导致。

但是该研究所纳入的研究对象仅为白人老年女性，因此仍需进一步的研究扩大人群以更好的探究止痛药与听力损失之间的联系。

原始出处：

[1] Catharine Paddock. Prolonged use of some painkillers tied to hearing loss in women. MNT, 15 December 2016.

[2] Brian M. Lin et al., Duration of analgesic use and risk of hearing loss in women, American Journal of Epidemiology. 14 December 2016.


本文系梅斯医学（MedSci）原创编译整理，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (57)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-03 cooco

    #止痛剂#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-20 zmjlilei

    感谢分享一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-19 zmjlilei

    感谢分享一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-18 zmjlilei

    感谢分享一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-17 zmjlilei

    感谢分享一下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-16 zmjlilei

    感谢分享一下

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-15 zmjlilei

    感谢分享一下

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-14 zmjlilei

    感谢分享一下

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-13 zmjlilei

    感谢分享一下

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1980776, encodeId=e6851980e7644, content=<a href='/topic/show?id=2f2a631644f' target=_blank style='color:#2F92EE;'>#止痛剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63164, encryptionId=2f2a631644f, topicName=止痛剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbcc223, createdName=cooco, createdTime=Tue Jan 03 00:33:00 CST 2017, time=2017-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171525, encodeId=e16b1e1525b7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 20 08:40:41 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171319, encodeId=1eb71e1319da, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 19 09:42:51 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171088, encodeId=7d051e1088aa, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Wed Jan 18 12:12:34 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170869, encodeId=67cf1e086945, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Tue Jan 17 09:20:48 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170625, encodeId=a06d1e062512, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Mon Jan 16 02:17:27 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170457, encodeId=0d3f1e0457ac, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sun Jan 15 09:16:23 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170285, encodeId=74031e0285b8, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Sat Jan 14 11:17:23 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=170011, encodeId=04cd1e00119e, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Fri Jan 13 08:59:51 CST 2017, time=2017-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=169786, encodeId=d0e2169e86e7, content=感谢分享一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a161743757, createdName=zmjlilei, createdTime=Thu Jan 12 08:46:46 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-12 zmjlilei

    感谢分享一下

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

AM J PREV MED：孕妇听力损失，小心早产和低出生体重儿

来自美国的研究人员开展了一项研究，这项研究的目的是估计有听力损失的孕妇的分娩结局，并且研究人员将这些女性与那些没有听力损失的女性进行了比较。本研究于2015年检测了2008-2011年全国住院样本的数据，比较了有听力损失和没有听力损失女性的分娩结果。出生结局包括早产和低出生体重。多元回归分析比较了有听力损失和没有听力损失女性的分娩结果，并且研究人员对产妇年龄，种族和种族身份，医疗保险，合并症，医院

JCO：顺铂的耳毒性研究

众所周知癌症患者中广泛使用的顺铂具有耳毒性。近期有研究表明，对于生殖细胞瘤幸存者，增加增加顺铂剂量与听力损失显著相关。印第安那大学梅尔文和布伦西蒙癌症中心的癌症生存研究项目主任Lois B. Travis博士和他的同事们试图评估顺铂累积剂量和听觉能力之间的相关性，该研究纳入了488名（平均诊断年龄31岁；范围，15-49）已使用顺铂治疗的生殖细胞肿瘤患者。队列中的大多数患者接受博莱霉素，依托泊苷和